WORLD TRADE
ORGANIZATIONG/TBT/Notif.00/420
18 September 2000
(00-3686)
Committee on Technical Barriers to Trade
NOTIFICATION
The following notification is being circulated in accordance with Article 10.6.
1. Member to Agreement notifying:   ARGENTINA
If applicable, name of local government involved (Articles 3.2 and 7.2):
2. Agency responsible:   National Medicaments, Food and Medical Technology
Administration
Agency or authority designated to handle comments regarding the notification shall be
indicated if different from above:           
3. Notified under Article 2.9.2 [     ], 2.10.1 [ X  ], 5.6.2 [    ], 5.7.1 [    ], other:
4. Products covered (HS or CCCN where applicable, otherwise national tariff heading.
ICS numbers may be provided in addition, where applicable):   Medicines
5. Title, number of pages and language(s) of the notified document:   National
Medicaments, Food and Medical Technology Administration Regulation
ANMAT No. 2525/2000, (3 pages, in Spanish).
6. Description of content:  Rules to be followed by laboratories certified for medicines
containing cisapride as the main active ingredient.
7. Objective and rationale, including the na ture of urgent problems where applicable:
The measure has been taken because cisapride is regarded as an active ingredient
whose action is such that it should only be used strictly under prescription and medical
supervision, due to its dangerousness and the possible harmful effects of uncontrolled use.
8. Relevant documents:   -
9. Proposed date of adoption:  -
Proposed date of entry into force:  90 days from 4 September 2000.
10. Final date for comments:   -
11. Texts available from:  National enquiry point [X] or address, e-mail and telefax
number of the other body:
Enquiry point of the Argentine Republic
Dirección Nacional de Comercio Interior
Avda. J.A. Roca 651 Piso 4° Sector 22 (1322) Buenos AiresFax:  54 11 4349 4038
Tel.:  54 11 4349 4037
E-mail:  vcamal@secind.mecon.gov.ar